Hemas Holdings
Conglomerado de atención médica y cuidado personal de Colombo con distribución farmacéutica regional.
Hemas Holdings es un conglomerado de Sri Lanka con divisiones de atención médica y bienes de consumo. Fundada en 1948, su división de bienes de consumo produce productos de cuidado personal (Baby Cheramy, Clogard) y su división de atención médica distribuye productos farmacéuticos en el sur y sudeste de Asia.
- Type
- brand seeking distribution
- Location
- Colombo, Sri Lanka
- Founded
- 1948
- Website
- hemas.com
- Categories
- Suministros médicos y sanitarios, Cuidado personal
- Markets
- Bangladés, Pakistán, Malasia, Emiratos Árabes Unidos
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
- lei-lapsed (amber), checked 2026-08-30 GLEIF global LEI register (golden copy)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)